- Home
- Publications
- Publication Search
- Publication Details
Title
Fusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 1, Pages 177
Publisher
MDPI AG
Online
2018-01-09
DOI
10.3390/ijms19010177
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chitosan nanoparticle-based delivery of fused NKG2D–IL-21 gene suppresses colon cancer growth in mice
- (2017) Lunmei Tan et al. International Journal of Nanomedicine
- A Novel Fusion Antibody Exhibits Antiangiogenic Activity and Stimulates NK Cell-mediated Immune Surveillance Through Fused NKG2D Ligand
- (2017) Desmond O. Acheampong et al. JOURNAL OF IMMUNOTHERAPY
- MICA/IL-12: A novel bifunctional protein for killer cell activation
- (2017) Ashlee Tietje et al. ONCOLOGY REPORTS
- A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma
- (2016) Tong Wang et al. CANCER LETTERS
- Mechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell–Treated Mice
- (2016) Marie-Louise Sentman et al. JOURNAL OF IMMUNOLOGY
- Driving CAR T-cells forward
- (2016) Hollie J. Jackson et al. Nature Reviews Clinical Oncology
- Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy
- (2016) Reza Ghasemi et al. Nature Communications
- VEGFR2 targeted antibody fused with MICA stimulates NKG2D mediated immunosurveillance and exhibits potent anti-tumor activity against breast cancer
- (2016) Wei Xei et al. Oncotarget
- Delivery of human NKG2D-IL-15 fusion gene by chitosan nanoparticles to enhance antitumor immunity
- (2015) Chen Yan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Human fused NKG2D–IL-15 protein controls xenografted human gastric cancer through the recruitment and activation of NK cells
- (2015) Yan Chen et al. Cellular & Molecular Immunology
- Lentiviral vectors in cancer immunotherapy
- (2015) Robyn AA Oldham et al. Immunotherapy
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice
- (2015) Heather VanSeggelen et al. MOLECULAR THERAPY
- NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
- (2015) Wei Wang Frontiers in Immunology
- MICA polymorphism: biology and importance in cancer
- (2014) D. Chen et al. CARCINOGENESIS
- Utilizing adenovirus vectors for gene delivery in cancer
- (2014) Dayananda Kasala et al. Expert Opinion on Drug Delivery
- MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation
- (2014) A Tietje et al. GENE THERAPY
- An Fc-optimized NKG2D-immunoglobulin G fusion protein for induction of natural killer cell reactivity against leukemia
- (2014) Julia Steinbacher et al. INTERNATIONAL JOURNAL OF CANCER
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- Fc-Optimized NKG2D–Fc Constructs Induce NK Cell Antibody-Dependent Cellular Cytotoxicity against Breast Cancer Cells Independently of HER2/neu Expression Status
- (2014) Stefanie Raab et al. JOURNAL OF IMMUNOLOGY
- Treatment With a Fusion Protein of the Extracellular Domains of NKG2D to IL-15 Retards Colon Cancer Growth in Mice
- (2014) Yan Xia et al. JOURNAL OF IMMUNOTHERAPY
- Targeting multiple types of tumors using NKG2D-coated iron oxide nanoparticles
- (2014) Ming-Ru Wu et al. NANOTECHNOLOGY
- Interleukin-21: a double-edged sword with therapeutic potential
- (2014) Rosanne Spolski et al. NATURE REVIEWS DRUG DISCOVERY
- Current Progress in Gene Delivery Technology Based on Chemical Methods and Nano-carriers
- (2014) Lian Jin et al. Theranostics
- Efficacy and Mechanism-of-Action of a Novel Superagonist Interleukin-15: Interleukin-15 Receptor Su/Fc Fusion Complex in Syngeneic Murine Models of Multiple Myeloma
- (2013) W. Xu et al. CANCER RESEARCH
- A Chimeric Receptor with NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor Cells
- (2013) Y.-H. Chang et al. CANCER RESEARCH
- Chimeric NKG2D CAR-Expressing T Cell-Mediated Attack of Human Ovarian Cancer Is Enhanced by Histone Deacetylase Inhibition
- (2013) De-Gang Song et al. HUMAN GENE THERAPY
- NKG2D CAR T-cell therapy inhibits the growth of NKG2D ligand heterogeneous tumors
- (2013) Paul Spear et al. IMMUNOLOGY AND CELL BIOLOGY
- The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma
- (2013) Achim Rothe et al. INTERNATIONAL JOURNAL OF CANCER
- Mouse Tumor Vasculature Expresses NKG2D Ligands and Can Be Targeted by Chimeric NKG2D-Modified T Cells
- (2013) T. Zhang et al. JOURNAL OF IMMUNOLOGY
- NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study
- (2012) Esther M de Kruijf et al. BMC CANCER
- Chimeric Antigen Receptor T Cells Shape Myeloid Cell Function within the Tumor Microenvironment through IFN- and GM-CSF
- (2012) P. Spear et al. JOURNAL OF IMMUNOLOGY
- Magnetic Nanoparticles for Cancer Diagnosis and Therapy
- (2012) Mehmet V. Yigit et al. PHARMACEUTICAL RESEARCH
- Redirecting T Cells to Ewing's Sarcoma Family of Tumors by a Chimeric NKG2D Receptor Expressed by Lentiviral Transduction or mRNA Transfection
- (2012) Manfred Lehner et al. PLoS One
- Tumor-Targeted Delivery of IL-2 by NKG2D Leads to Accumulation of Antigen-Specific CD8+ T Cells in the Tumor Loci and Enhanced Anti-Tumor Effects
- (2012) Tae Heung Kang et al. PLoS One
- Cancer Immunotherapy Using a Bispecific NK Receptor Fusion Protein that Engages both T Cells and Tumor Cells
- (2011) T. Zhang et al. CANCER RESEARCH
- Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells
- (2011) A Barber et al. GENE THERAPY
- CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
- (2011) Barbara Savoldo et al. JOURNAL OF CLINICAL INVESTIGATION
- Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity
- (2011) C Kellner et al. LEUKEMIA
- Induction of In Vitro and In Vivo NK Cell Cytotoxicity Using High-Avidity Immunoligands Targeting Prostate-Specific Membrane Antigen in Prostate Carcinoma
- (2011) R. D. Jachimowicz et al. MOLECULAR CANCER THERAPEUTICS
- Delivery of NKG2D Ligand Using an Anti-HER2 Antibody-NKG2D Ligand Fusion Protein Results in an Enhanced Innate and Adaptive Antitumor Response
- (2010) H.-M. Cho et al. CANCER RESEARCH
- ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients
- (2010) Roger W. McGilvray et al. INTERNATIONAL JOURNAL OF CANCER
- The Fas–FADD death domain complex structure reveals the basis of DISC assembly and disease mutations
- (2010) Liwei Wang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- In vitro and in vivo delivery of novel anticancer fusion protein MULT1E/FasTI via adenoviral vectors
- (2009) H S R Kotturi et al. CANCER GENE THERAPY
- The Many Roles of FAS Receptor Signaling in the Immune System
- (2009) Andreas Strasser et al. IMMUNITY
- Chimeric NKG2D T Cells Require Both T Cell- and Host-Derived Cytokine Secretion and Perforin Expression to Increase Tumor Antigen Presentation and Systemic Immunity
- (2009) A. Barber et al. JOURNAL OF IMMUNOLOGY
- Chimeric NKG2D Expressing T Cells Eliminate Immunosuppression and Activate Immunity within the Ovarian Tumor Microenvironment
- (2009) A. Barber et al. JOURNAL OF IMMUNOLOGY
- Novel Human Interleukin-15 Agonists
- (2009) X. Zhu et al. JOURNAL OF IMMUNOLOGY
- Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
- (2009) C. Carpenito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone deacetylase inhibitors sensitize tumour cells for cytotoxic effects of natural killer cells
- (2008) Mareike Schmudde et al. CANCER LETTERS
- Chimeric NKG2D receptor–expressing T cells as an immunotherapy for multiple myeloma
- (2008) Amorette Barber et al. EXPERIMENTAL HEMATOLOGY
- Tumor cells expressing a fusion protein of MULT1 and Fas are rejected in vivo by apoptosis and NK cell activation
- (2008) H S R Kotturi et al. GENE THERAPY
- Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D
- (2008) Cai Zhang et al. HUMAN IMMUNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started